About Sareum
Sareum is a company based in Cambridge (United Kingdom) founded in 2003.. Sareum operates in a competitive market with competitors including Moderna, Horizon Therapeutics, Forge Biologics, argenx and Annexon, among others.
- Headquarter Cambridge, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sareum Holdings Plc
-
Annual Revenue
$0 (USD)0as on Jun 30, 2024
-
Net Profit
$-6.08 M (USD)-29.77as on Jun 30, 2025
-
EBITDA
$-4.66 M (USD)26.55as on Jun 30, 2025
-
Latest Funding Round
$6.37 M (USD), Post-IPO
Aug 03, 2023
-
Investors
UK Research and Innovation
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sareum
Sareum is a publicly listed company on the LSE with ticker symbol SAR in UK, operating in the Miscellaneous sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Sareum
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $6.4M
-
First Round
First Round
(14 Nov 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Post-IPO - Sareum | Valuation |
investors |
|
| Jun, 2021 | Amount | Post-IPO - Sareum | Valuation |
investors |
|
| Oct, 2020 | Amount | Grant - Sareum | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sareum
Sareum has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include UK Research and Innovation and RiverFort Global Opportunities. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Natural resource investments are targeted by the infrastructure fund.
|
Founded Year | Domain | Location | |
|
Research and innovation funding is managed for UK advancement.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sareum
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sareum
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sareum Comparisons
Competitors of Sareum
Sareum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Horizon Therapeutics, Forge Biologics, argenx and Annexon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for autoimmune diseases are developed by the company.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sareum
Frequently Asked Questions about Sareum
When was Sareum founded?
Sareum was founded in 2003 and raised its 1st funding round 14 years after it was founded.
Where is Sareum located?
Sareum is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
What does Sareum do?
Developer of small molecule therapeutics for cancer and autoimmune diseases. It has SKIL (Sareum Kinase Inhibitor Library) platform for drug discovery which is used to inhibit many different kinases. The companys drug pipeline includes checkpoint kinase 1 (Chk1) used for the treatment of neuroblastoma, lymphoma and acute myeloid leukaemia (AML) and in combination with chemotherapy for the treatment of lung, pancreatic and colon cancer. The companys other product includes TYK2 inhibitor which is used for the treatment of autoimmune diseases such as psoriasis, lupus and colon cancer.
Who are the top competitors of Sareum?
Sareum's top competitors include Moderna, argenx and Forge Biologics.
Is Sareum publicly traded?
Yes, Sareum is publicly traded on LSE under the ticker symbol SAR.
Who are Sareum's investors?
Sareum has 2 investors. Key investors include UK Research and Innovation, and RiverFort Global Opportunities.
What is Sareum's ticker symbol?
The ticker symbol of Sareum is SAR on LSE.